Skip to main content
SpringerLink
Log in

HIV Infection and Cancer

  • Chapter
AIDS in Africa

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cook-Mozaffari P, Newton R, Beral V, et al. The geographical distribution of Kaposi’s sarcoma and of lymphomas in Africa before the AIDS epidemic. Br J Cancer, 1998;78:1521–1528.

    PubMed  CAS  Google Scholar 

  2. Oettlé AG. Geographical and racial differences in the frequency of Kaposi’s sarcoma as evidence of environmental or genetic causes. Acta unio int contra cancrum, 1962;18:330–363.

    PubMed  Google Scholar 

  3. Templeton AC. Kaposi’s sarcoma. In: Sommers SC, Rosen PP, eds. Pathology Annual. New York, Appleton: Century-Crofts, 1981;315–336.

    Google Scholar 

  4. Hutt MSR. Classical and endemic form of Kaposi’s sarcoma. A review. Antibiot Chemother, 1984; 32:12–17.

    Google Scholar 

  5. Parkin DM, Muir CS, Whelan SL, et al. Cancer Incidence in Five Continents. IARC Scientific Publication, 1992; volume 6:No. 20.

    Google Scholar 

  6. Beral V, Newton R. Overview of the epidemiology of immunodeficiency-associated cancers. Monogr Natl Cancer Inst, 1998:23;1–6.

    PubMed  Google Scholar 

  7. Pollock BH, Jenson HB, McClain KL, et al. Risk factors for HIV-related malignancies in children. J Aquir Immune Defic Syndr Hum Retrovirol, 1997;14:A17

    Google Scholar 

  8. Grulich A, Wan X, Law M, et al. Rates of non-AIDS defining cancers in people with AIDS. J Aquir Immune Defic Syndr Hum Retrovirol, 1997;14: A18.

    Google Scholar 

  9. Rabkin C. Epidemiology of malignancies other than Kaposi’s sarcoma and non-Hodgkin’s lymphoma in HIV infection. J Aquir Immune Defic Syndr Hum Retrovirol, 1997;14:A12.

    Google Scholar 

  10. Dorffel J. Histogenesis of multiple idiopathic hemorrhagic sarcoma of Kaposi. Arch Dermatol Syph, 1932;26:608–634.

    Google Scholar 

  11. Tappero JW, Conant MA, Wolfe SF, et al. Kaposi’s sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol, 1993;28:371–395.

    Article  PubMed  CAS  Google Scholar 

  12. Casabona J, Salas T, Salinas R. Trends and survival in AIDS-associated malignancies. Eur J Cancer, 1993;29A:877–881.

    PubMed  CAS  Google Scholar 

  13. Ziegler JL, Katongole-Mbidde E. Kaposi’s sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection. Int J Cancer, 1996;65:200–203.

    Article  PubMed  CAS  Google Scholar 

  14. Mbulaiteye SM, Ziegler JL, Katongole-Mbidde E, et al. Kaposi’s sarcoma study group. Risk factors for childhood Kaposi’s sarcoma in Uganda: a casecontrol study. Abstract 7. J Aquir Immune Defic Syndr Hum Retrovirol, 1997;14:A18.

    Google Scholar 

  15. Newton R, Beral V, Weiss R. Human Immunodeficiency Virus Infection and Cancer. In: Newton R, Beral V, Weiss R, eds. Infections and Human Cancer. Cancer Surveys Series, volume 33. Cold Spring Harbor Cold Spring Harbor Laboratory Press, 1999.

    Google Scholar 

  16. Biggar RJ, Horm J, Fraumeni JF, et al. Incidence of Kaposi’s sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973–1981. J Natl Cancer Inst, 1984;73:89–94.

    PubMed  CAS  Google Scholar 

  17. Grulich AE, Beral V, Swerdlow AJ. Kaposi’s sarcoma in England and Wales before the AIDS epidemic. Br J Cancer, 1992;66:1135–1137.

    PubMed  CAS  Google Scholar 

  18. Hjalgrim H, Melbye M, Pukkala E, et al. Epidemiology of Kaposi’s sarcoma in the Nordic countries prior to the AIDS epidemic. Br J Cancer, 1996;74:1499–1502.

    PubMed  CAS  Google Scholar 

  19. Rabkin CS, Biggar RJ, Horm JW. Increasing incidence of cancers associated with the human immunodeficiency virus epidemic. Int J Cancer, 1991;47:692–696.

    PubMed  CAS  Google Scholar 

  20. Wabinga HR, Parkin DM, Wabwire-Mangen F, et al. Cancer in Kampala, Uganda, in 1989–91: Changes in incidence in the era of AIDS. Int J Cancer, 1993:54:26–36.

    PubMed  CAS  Google Scholar 

  21. Bassett MT, Chokunonga E, Mauchaza B, et al. Cancer in the African population of Harare, Zimbabwe in 1990–92. Int J Cancer, 1995;63:29–36.

    PubMed  CAS  Google Scholar 

  22. Sitas F, Madhoo J, Wessie J. Incidence of histologically. diagnosed cancer in South Africa, 1993–1995. Johannesburg: National Cancer Registry of South Africa, South African Institute of Medical Research, 1998.

    Google Scholar 

  23. Sitas F, Bezwoda WR, Levin V, et al. Association between human immunodeficiency virus type 1 infection and cancer in the black population of Johannesburg and Soweto, South Africa. Br J Cancer, 1997;75:1704–1707.

    PubMed  CAS  Google Scholar 

  24. Newton R, Grulich A, Beral Y et al. Cancer and HIV infection in Rwanda. Lancet, 1995;345: 1378–1379.

    Article  PubMed  CAS  Google Scholar 

  25. Sitas F, Pacell-Norman R, Carrara H, et al. The spectrum of HIV-1 related cancers in South Africa. Int J Cancer, 2000;88:489–492.

    Article  PubMed  CAS  Google Scholar 

  26. Newton R, Ziegler J, Beral V, et al. Uganda Kaposi’s Sarcoma Study Group. A case-control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda. Int J Cancer, 2001;92:622–627.

    Article  PubMed  CAS  Google Scholar 

  27. Chang Y, Cesarman E, Pessin MS, et al. Identification of Herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science, 1994;266:1865–1869.

    PubMed  CAS  Google Scholar 

  28. Boshoff C. Kaposi’s sarcoma associated herpesvirus. In: Newton R, Beral V, Weiss R, eds. Infections and Human cancer. Cancer Surveys Series Volume 33. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1999.

    Google Scholar 

  29. Boshoff C, Schulz TF, Kennedy MM, et al. Kaposi’s sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med, 1995;1:1274–1278.

    Article  PubMed  CAS  Google Scholar 

  30. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi’s sarcoma-associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi’s sarcoma. Lancet, 1995;346:799–802.

    Article  PubMed  CAS  Google Scholar 

  31. Gao SJ, Kingsley L, Hoover DR, et al. Seroconversion of antibodies to Kaposi’s sarcomaassociated herpesvirus-related latent nuclear antigens prior to onset of Kaposi’s sarcoma. New Engl J Med, 1996;335:233–241.

    Article  PubMed  CAS  Google Scholar 

  32. Gao SJ, Kingsley L, Li M, et al. Seroprevalence of Kaposi’s sarcoma-associated herpesvirus antibodies among Americans, Italians and Ugandans with and without Kaposi’s sarcoma. Nat Med, 1996;2:925–928.

    Article  PubMed  CAS  Google Scholar 

  33. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi’s sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet, 1996;348:1133–1138.

    Article  PubMed  CAS  Google Scholar 

  34. Sitas F, Carrara H, Beral V, et al. Antibodies against human herpesvirus 8 in black South African patients with cancer. New Engl J Med, 1999;340:1863–1871.

    PubMed  CAS  Google Scholar 

  35. de Thé G, Geser A, Day NE, et al. Epidemiological evidence for causal relationship between Epstein-Barr Virus and Burkitt’s lymphoma from a Ugandan prospective study. Nature, 1978;274:751–761.

    Google Scholar 

  36. de Thé G, Lavoue MF, Muenz L. Differences in EBV antibody titres of patients with nasopharyngeal carcinoma originating from areas of high, intermediate and low incidence areas. In: de Thé G, Ito Y, eds. Nasopharyngeal Carcinoma: Etiology and Control. Lyon: International Agency for Research on Cancer, 1978. (IARC Scientific Publication no. 20).

    Google Scholar 

  37. Martin JN, Ganem DE, Osmond DH, et al. Sexual transmission and the natural history of Human Herpesvirus-8 infection. New Engl J Med, 1998;338:948–954.

    PubMed  CAS  Google Scholar 

  38. Melbye M, Cook PM, Hjalgrim H, et al. Risk factors for HHV-8 seropositivity and progression to Kaposi’s sarcoma in a cohort of homosexual men, 1981–96. J Aquir Immune Defic Syndr Hum Retrovirol, 1997;14:A16 S1.

    Google Scholar 

  39. Grulich A, Olsen S, Hendry O, et al. Route of transmission of Kaposi’s sarcoma associated herpesvirus. J Aquir Immune Defic Syndr Hum Retrovirol, 1997;14:A16 S2.

    Google Scholar 

  40. Wilkinson D, Sheldon, J, Gilks C, et al. Prevalence of infection with Human Herpesvirus 8 (HHV-8)/Kaposi’s sarcoma herpesvirus (KSHV) in rural South Africa. S Afr Med J, 1999;89:554–557.

    PubMed  CAS  Google Scholar 

  41. Bourboulia D, Whitby D, Boshoff C, et al. Serologic evidence for mother to child transmission of Kaposi sarcoma associated herpesvirus infection. JAMA, 1998;280:31–32.

    Article  PubMed  CAS  Google Scholar 

  42. Mayama S, Cuervas LE, Sheldon J, et al. Prevalence and transmission of Kaposi’s sarcoma associated herpesvirus (Human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer, 1998;77:817–820.

    Article  PubMed  CAS  Google Scholar 

  43. Sitas F, Newton R, Boshoff C. Probability of mother-to-child transmission of HHV-8 increases with increasing maternal antibody titre for HHV-8. New Engl J Med, 1999;340:1923.

    PubMed  CAS  Google Scholar 

  44. Abdool-Karim SS, Coovadia HC, Windsor IM, et al. The prevalence and transmission of Hepatitis B virus infection in urban, rural and institutional black children of Natal/KwaZulu, South Africa. Int J Epidemiol, 1988;17:168–173.

    PubMed  CAS  Google Scholar 

  45. Beral V, Peterman TA, Berkelman RL, et al. Kaposi’s sarcoma among persons with AIDS: a sexually transmitted infection? Lancet, 1990;335:123–128.

    Article  PubMed  CAS  Google Scholar 

  46. Ziegler JL, Newton R, Katongole-Mbidde E, et al. Risk factors for HIV-associated Kaposi’s sarcoma in Uganda: a case-control study of 1026 adults. AIDS, 1997;11:1619–1626.

    Article  PubMed  CAS  Google Scholar 

  47. Ziegler J and the Uganda Kaposi’s Sarcoma Study Group. Wealth and soil exposure are risk factors for endemic Kaposi’s sarcoma in Uganda. J Aquir Immune Defic Syndr Hum Retrovirol, 1998; 17.A12.

    Google Scholar 

  48. Ziegler JL. Endemic Kaposi’s sarcoma in Africa and local volcanic soils. Lancet, 1993;342:1348–1351.

    PubMed  CAS  Google Scholar 

  49. Oksenhendler E, Cazals-Hatem D, Schulz TF, et al. Transient angiolymphoid hyperplasia and Kaposi’s sarcoma after primary infection with human herpes virus 8 in a patient with Human immunodeficiency virus infection. New Engl J Med, 1998;338:1585–1590.

    Article  PubMed  CAS  Google Scholar 

  50. Vieira D, Hunag L, Koelle D, et al. Transmissible Kaposi’s-associated herpesvirus (Human herpesvirus 8) in saliva of men with a history of Kaposi’s sarcoma. J Virol, 1997;71:7083–7087.

    PubMed  CAS  Google Scholar 

  51. IARC monograph on the evaluation of carcinogenic risks to humans. Human immunodeficiency viruses. and human T-cell lymphotropic viruses. Volume 67. Lyon, France: IARC, 1996.

    Google Scholar 

  52. Beral V, Peterman TA, Berkelman R, et al. AIDS-associated non-Hodgkin lymphoma. Lancet, 1991:337:805–809.

    Article  PubMed  CAS  Google Scholar 

  53. Kinlen LJ, Sheil AG, Peto J, et al. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J, 1979;2:1461–1466.

    Article  PubMed  CAS  Google Scholar 

  54. Pluda JM, Venzon DJ, Tosato G, et al. Parameters affecting the development of non-Hodgkin’s lymphoma in patients with severe human immunodeficiency virus infection receiving anti-retroviral therapy. J Clin Oncol, 1993;11:1099–1107.

    PubMed  CAS  Google Scholar 

  55. Serraino D, Salamina G, Franceschi S, et al. The epidemiology of non-Hodgkin’s lymphoma in the World Health Organization European Region. Br J Cancer, 1992;66:912–916.

    PubMed  CAS  Google Scholar 

  56. Lyter D, Besley D, Thackeray R, et al. Incidence of malignancies in the Multicenter AIDS Cohort Study (MACS). Proceedings ASCO, 1994;13:50. Abstract A2.

    Google Scholar 

  57. Wilkes MS, Felix JC, Fortwin AH, et al. Value of necropsy in acquired immunodeficiency syndrome. Lancet, 1988;2:85–88

    PubMed  CAS  Google Scholar 

  58. Lucas SB, Diomande M, Hounnou A, et al. HIV-associated lymphoma in Africa: an autopsy study on Côte D’Ivoire. Int J Cancer, 1994;59: 20–24.

    PubMed  CAS  Google Scholar 

  59. Templeton AC. Tumours of the eye and adnexa. Recent Results Cancer Res, 1973;41:203–214.

    PubMed  CAS  Google Scholar 

  60. Lee GA, Williams G, Hirst LW, et al. Risk Factors in the Development of Ocular Surface Epithelial Dysplasia. Ophthalmol, 1994; 101:360–364.

    CAS  Google Scholar 

  61. Newton R, Ferlay J, Reeves G, et al. Incidence of squamous cell carcinoma of the eye increases with increasing levels of ambient solar ultraviolet radiation. Lancet, 1996;347:1450–1451.

    PubMed  CAS  Google Scholar 

  62. IARC monograph on the evaluation of carcinogenic risks to Humans. Volume 55. Solar and Ultraviolet Radiation. Lyon: IARC, 1992.

    Google Scholar 

  63. Winward KE, Curtin VT. Conjunctival squamous cell carcinoma in a patient with human immunodeficiency virus infection. Am J Ophthalmol, 1989;107:554–555.

    PubMed  CAS  Google Scholar 

  64. Kim RY, Seiff SR, Howes EL Jr, et al. Necrotizing scleritis secondary to Conjunctival squamous cell carcinoma in acquired immunodeficiency syndrome. Am J Ophthalmol, 1990;109:231–233.

    PubMed  CAS  Google Scholar 

  65. Kestelyn P, Stevens AM, Ndayambaje A, et al. HIV and Conjunctival malignancies. Lancet, 1990;336:51–52.

    Article  PubMed  CAS  Google Scholar 

  66. Ateenyi-Agaba C. Conjunctival squamous cell carcinoma associated with HIV infection in Kampala, Uganda. Lancet, 1995:345:695–696.

    Article  PubMed  CAS  Google Scholar 

  67. Waddell KM, Lewallen S, Lucas SB, et al. Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi. Br J Ophthalmol, 1996;80:503–508.

    PubMed  CAS  Google Scholar 

  68. Goedert JJ, Coté TR. Conjunctival malignant disease with AIDS in USA. Lancet, 1995;ii:257–258.

    Google Scholar 

  69. Parkin DM, Wabinga H, Nambooze S, et al. AIDS-related cancers in Africa: maturation of the epidemic in Uganda. AIDS, 1999;13:2563–2570.

    Article  PubMed  CAS  Google Scholar 

  70. Kushner FH, Mushen RL. Conjunctival squamous cell carcinoma combined with malignant lymphoma. Am J Ophthalmol, 1975;80:503–506.

    PubMed  CAS  Google Scholar 

  71. IARC monograph on the evaluation of carcinogenic risks to Humans. Volume 64. Human papillomaviruses. Lyon: IARC, 1995.

    Google Scholar 

  72. Newton R. A review of the aetiology of squamous cell carcinoma of the conjunctiva. Br J Cancer, 1996:74:1511–1513.

    PubMed  CAS  Google Scholar 

  73. Margo CE, Groden LR. Squamous cell carcinoma of the cornea and conjunctiva following a thermal burn of the eye. Cornea, 1986;5:185–188.

    PubMed  CAS  Google Scholar 

  74. Franceschi S, Dal Maso L, Arniani S, et al. Cancer and AIDS Registry Linkage Study. Risk of cancer other than Kaposi’s sarcoma and non-Hodgkin’s lymphoma in persons with AIDS in Italy. Br J Cancer, 1998:78:966–970.

    PubMed  CAS  Google Scholar 

  75. Goedert JJ, Coté TR, Virgo P, et al. AIDS-Cancer Match Study Group. Spectrum of AIDS-associated malignant disorders. Lancet, 1998;351:1833–1839.

    Article  PubMed  CAS  Google Scholar 

  76. Selik RM, Rabkin CS. Caticer death rates associated with Human Immunodeficiency Virus infection in the United States. J National Cancer Institute, 1998;90:1300–1302.

    CAS  Google Scholar 

  77. La Ruche G, You B, Mensah-Ado I, et al. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women. Int J Cancer, 1998;74:480–486.

    Google Scholar 

  78. IARC monograph on the evaluation of carcinogenic risks to Humans. Volume 59. Hepatitis viruses. Lyon: IARC, 1994.

    Google Scholar 

  79. Birkland SA, Storm HH, Lamm LU, et al. Cancer risk after renal transplantation in the Nordic countries, 1964–1986. Int J Cancer, 1995;60:183–189.

    Google Scholar 

  80. Klepp O, Dahl O, Stenwig JT. Association of Kaposi’s sarcoma and prior immunosuppressive therapy. Cancer, 1978;42:2626–2630.

    PubMed  CAS  Google Scholar 

  81. Harwood AR, Osoba D, Hofstader SL, et al. Kaposi’s sarcoma in recipients of renal transplants. Am J Med, 1979;67:759–765.

    Article  PubMed  CAS  Google Scholar 

  82. Penn I. Kaposi’s sarcoma in organ transplant recipients. Transplantation, 1979;27:8–11.

    PubMed  CAS  Google Scholar 

  83. Sheil AG, Flavel S, Disney AP, et al. Cancer incidence in renal transplant patients treated with azathioprine or cyclosporin. Transplant Proc, 1987;19: 2214–2216.

    PubMed  CAS  Google Scholar 

  84. Qunibi W, Akhtar M, Sheth K, et al. Kaposi’s sarcoma: the most common tumour after renal transplantation in Saudi Arabia. Am J Med, 1988;84:25–232.

    Google Scholar 

  85. Frances C, Farge D, Boisnic S. Syndrome de Kaposi des transplantes. J Mal Vasc, 1991;16:163–165.

    PubMed  CAS  Google Scholar 

  86. Ensoli B, Gendelman R, Markham P, et al. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi’s sarcoma. Nature, 1994;371:674–680.

    Article  PubMed  CAS  Google Scholar 

  87. Vogel J, Hinrichs SH, Reynolds RK, et al. The HIV tat gene induces dermal lesions resembling Kaposi’s sarcoma in transgenic mice. Nature, 1988;335:606–611.

    PubMed  CAS  Google Scholar 

  88. Roth WK, Brandstetter H, Sturzl M. Cellular and molecular features of HIV-associated Kaposi’s sarcoma. AIDS, 1992;6:895–913.

    PubMed  CAS  Google Scholar 

  89. Ariyoshi K, Schim van der Loeff M, Cook P, et al. Kaposi’s sarcoma in the Gambia, West Africa is less frequent in Human Immunodeficiency Virus type 2 than in Human Immunodeficiency Virus type 1 infection despite a high prevalence of Human Herpes Virus 8. J Hum Virol, 1998;1:193–199.

    PubMed  CAS  Google Scholar 

  90. Bayley AC, Cheinsong-Popov R, Dalgleish AG, et al. HTLV-III serology distinguishes atypical and endemic Kaposi’s sarcoma in Africa. Lancet, 1985;I:359–361.

    Google Scholar 

  91. Starzl TE, Porter KA, Iwatsuki S, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet, 1984;I:583–587.

    Google Scholar 

  92. Herndier BG, Kaplan LD, McGrath MS. Pathogenesis of AIDS lymphomas. AIDS, 1994;8:1025–1049.

    PubMed  CAS  Google Scholar 

  93. Muller JR, Janz S, Goedert JJ, et al. Persistence of immunoglobulin heavy chain/c-myc recombination-positive lymphocytes clones in the blood of human immunodeficiency virus-infected homosexual men. Proc Natl Acad Sci USA, 1995;92:6577–6581.

    PubMed  CAS  Google Scholar 

  94. Parkin DM, Pisani P, Munoz N, et al. The global health burden of infection associated cancers. In: Newton R, Beral V, Weiss R, eds. Infections and. Human Cancer. Cancer Surveys Series, volume 33. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1999.

    Google Scholar 

  95. International Collaboration on HIV and Cancer. The impact of highly active anti-retroviral therapy on the incidence of cancer in people infected with the Human Immunodeficiency Virus. J National Cancer Institute, 2000;92:1823–1830.

    Google Scholar 

  96. Rickinson A. The role of herpesviruses in immune deficiency-associated lymphomas. J Acquir Immune Defic Syndr Hum Retrovirol, 1997;14:A15.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Research UK Epidemiology Unit, Radcliffe Infirmary, Oxford, United Kingdom

    Robert Newton

  2. Cancer Epidemiology Research Group, National Cancer Registry, South African Institute for Medical Research, Johannesburg, South Africa

    Freddy Sitas

  3. Liverpool School of Tropical Medicine and the Africa Centre & Hlabisa Hospital, KwaZulu Natal, South Africa

    Martin Dedicoat

  4. Cancer Risk Program, UCSF Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA

    John L. Ziegler

Authors
  1. Robert Newton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Freddy Sitas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martin Dedicoat
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John L. Ziegler
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Harvard AIDS Institute Mary Woodard Lasker Professor of Health Sciences Harvard University, Boston, Massachusetts, USA

    Max Essex DVM, PhD (Chairman) & Richard G. Marlink MD (Senior Research and Executive Director) (Chairman) &  (Senior Research and Executive Director)

  2. Laboratory of Bacteriology and Virology CHU Le Dantec, Université Cheikh Anta Diop, Dakar, Senegal

    Souleymane Mboup PharmD, PhD (Professor of Microbiology) (Professor of Microbiology)

  3. Department of Immunology and Infectious Diseases and the Harvard AIDS Institute, Harvard School of Public Health, Boston, Massachusetts, USA

    Phyllis J. Kanki DVM, DSc (Professor of Immunology and Infectious Diseases) & Molly Holme (Professor of Immunology and Infectious Diseases) & 

  4. Department of Nursing Education University of Botswana, Gaborone, Botswana

    Sheila D. Tlou PhD (Associate Professor) (Associate Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Newton, R., Sitas, F., Dedicoat, M., Ziegler, J.L. (2002). HIV Infection and Cancer. In: Essex, M., Mboup, S., Kanki, P.J., Marlink, R.G., Tlou, S.D., Holme, M. (eds) AIDS in Africa. Springer, Boston, MA. https://doi.org/10.1007/0-306-47817-X_23

Download citation

  • DOI: https://doi.org/10.1007/0-306-47817-X_23

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-46699-1

  • Online ISBN: 978-0-306-47817-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation